Related Experiment Video

Updated: Oct 18, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
05:57

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension

Published on: May 17, 2024

Can lowering homocysteine levels reduce the incidence of stroke?

P K Sarkar1, L Lambert

  • 1Department of Medicine, Good Hope Hospital, West Midlands, U.K.

Journal of Clinical Pharmacy and Therapeutics
|December 3, 1999
PubMed

Insights

High homocysteine levels (hyperhomocysteinaemia) are a significant risk factor for stroke and other vascular diseases. This review examines the impact of elevated plasma homocysteine on stroke disease.

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Clinical Biochemistry

Background:

  • Hyperhomocysteinaemia is an independent risk factor for vascular diseases.
  • Atherosclerotic and thromboembolic conditions are linked to elevated homocysteine.
  • Stroke disease is a major concern in cardiovascular and neurological health.

Purpose of the Study:

  • To review the role of high plasma homocysteine levels in stroke disease.
  • To consolidate current understanding of hyperhomocysteinaemia's impact on cerebrovascular events.

Main Methods:

  • Literature review of studies investigating homocysteine and stroke.
  • Analysis of epidemiological and clinical data on hyperhomocysteinaemia.
  • Synthesis of evidence linking plasma homocysteine to stroke pathology.

Main Results:

  • Elevated homocysteine is associated with increased risk of stroke.
  • Mechanisms include endothelial dysfunction, inflammation, and thrombosis.
  • Specific thresholds of homocysteine may correlate with stroke risk.

Conclusions:

  • High plasma homocysteine is a modifiable risk factor for stroke.
  • Management of hyperhomocysteinaemia may reduce stroke incidence.
  • Further research is warranted to optimize therapeutic strategies.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...